泰凌医药(01011.HK)首席执行官变动

阿斯达克财经
19 May

泰凌医药(01011.HK) 公布,随着公司业务规模扩大及考虑下一步公司发展需要,吴铁希望投放更多时间专注于集团的发展战略等事宜,故此已辞任首席执行官职务,自今日(19日)起生效。他将继续担任董事会主席兼执行董事。

集团进一步宣布,张伯之已获委任为首席执行官,即日起生效。(sl/da)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10